GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OTCPK:MBGPF) » Definitions » 12-1 Month Momentum %

Moberg Pharma AB (Moberg Pharma AB) 12-1 Month Momentum % : -0.24% (As of May. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Moberg Pharma AB 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-06), Moberg Pharma AB's 12-1 Month Momentum % is -0.24%.

The industry rank for Moberg Pharma AB's 12-1 Month Momentum % or its related term are showing as below:

MBGPF's 12-1 Month Momentum % is ranked better than
93.72% of 1115 companies
in the Drug Manufacturers industry
Industry Median: -6.53 vs MBGPF: -0.24

Competitive Comparison of Moberg Pharma AB's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's 12-1 Month Momentum % falls into.



Moberg Pharma AB  (OTCPK:MBGPF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moberg Pharma AB  (OTCPK:MBGPF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Moberg Pharma AB 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB (Moberg Pharma AB) Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.